| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |